SCHEMBL781807

SCHEMBL781807

C[N+](C)(C)CC(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL9421128 0.96
Methyl Alcohol SCHEMBL23877952 0.96 MAPT (0.42)
Hydrochloric Acid SCHEMBL28705517 0.96
Water SCHEMBL28351618 0.96
SCHEMBL430642 0.83 SLC22A16 (0.44)
Formic Acid SCHEMBL3681464 0.83 SLC22A16 (0.44)
Prolonium SCHEMBL1649967 0.80 MAPT (0.52)
Prolonium SCHEMBL2889745 0.77 MAPT (0.57)
Prolonium SCHEMBL11723705 0.77 MAPT (0.50)
SCHEMBL8377853 0.77 MAPT (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850296-B Crystal form of thienoimidazole compound and preparation method thereof 杭州先为达生物科技股份有限公司 2025-03-11 CN claimed
EP-4441047-A1 CRYSTAL FORMS OF THIENOIMIDAZOLE COMPOUND AND PREPARATION METHOD THEREOF Hangzhou Sciwind Biosciences Co., Ltd. (CN) 2024-10-09 EP claimed
CN-116199880-B Amino acid-based ionic liquid, preparation method and application thereof, and water-based lubricant 烟台先进材料与绿色制造山东省实验室 2024-07-05 CN claimed
US-20240173314-A1 TREATMENT OF SICKLE CELL ANAEMIA ZYDUS LIFESCIENCES LTD. (IN) 2024-05-30 US claimed
WO-2024028744-A1 TREATMENT FOR APLASTIC ANEMIA (AA) ZYDUS LIFESCIENCES LIMITED (IN) 2024-02-08 WO claimed
EP-4308120-A1 TREATMENT FOR SICKLE CELL ANAEMIA Zydus Lifesciences Limited (IN) 2024-01-24 EP claimed
WO-2023248193-A1 TREATMENT FOR GLOMERULAR DISEASES ZYDUS LIFESCIENCES LIMITED (IN) 2023-12-28 WO claimed
US-20230241044-A1 TREATMENT FOR PSORIASIS AND SKIN INFLAMMATORY DISEASES ZYDUS LIFESCIENCES LIMITED (IN) 2023-08-03 US claimed
US-20230233550-A1 TREATMENT FOR THE INFLAMMATORY BOWEL DISEASE ZYDUS LIFESCIENCES LIMITED (IN) 2023-07-27 US claimed
WO-2023098852-A1 CRYSTAL FORMS OF THIENOIMIDAZOLE COMPOUND AND PREPARATION METHOD THEREOF HANGZHOU SCIWIND BIOSCIENCES CO., LTD. (CN) 2023-06-08 WO claimed
WO-2021181360-A1 NOVEL SALTS OF QUINOLONE COMPOUNDS CADILA HEALTHCARE LIMITED (IN) 2021-09-16 WO claimed
US-10112898-B2 Process for the preparation of saroglitazar pharmaceutical salts CADILA HEALTHCARE LIMITED (IN) 2018-10-30 US claimed
CN-105189493-B Novel Pyrazole Derivatives 持田制药株式会社 2017-04-12 CN claimed
US-20160207884-A1 POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF CADILA HEALTHCARE LIMITED (IN) 2016-07-21 US claimed
US-20160194280-A1 IMPROVED PROCESS FOR THE PREPARATION OF PYRROLE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2016-07-07 US claimed
EP-3039011-A1 POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF Cadila Healthcare Limited (IN) 2016-07-06 EP claimed
WO-2015029066-A1 POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF CADILA HEALTHCARE LIMITED (IN) 2015-03-05 WO claimed
CN-1938003-A Zinc preservative composition and method of use BAUSCH & LOMB (US) 2007-03-28 CN claimed
WO-2000072369-A1 METHOD FOR PRODUCING A DAMASCENE-TYPE INTERCONNECTION LEVEL COMPRISING AN ORGANIC DIELECTRIC COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2000-11-30 WO claimed
EP-0542969-B1 BIODEGRADABLE PARTICULATE VECTOR AND METHOD OF SYNTHESIS BIOVECTOR THERAPEUTICS SA (FR) 1997-05-07 EP claimed